Oslo, Norway Hadean Ventures appeared to be the VC, which was created in 2014. The main department of described VC is located in the Oslo. The venture was found in Europe in Norway.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Hadean Ventures, startups are often financed by aws Gru00fcnderfonds (aws Founders Fund), Wellington Partners, Ventech. The meaningful sponsors for the fund in investment in the same round are aws Gru00fcnderfonds (aws Founders Fund), Wellington Partners, Versant Ventures.
The important activity for fund was in 2019. The fund is constantly included in 2-6 deals per year. Deals in the range of 10 - 50 millions dollars are the general things for fund. Speaking about the real fund results, this VC is 30 percentage points more often commits exit comparing to other organizations.
Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. The fund has exact preference in some founders of portfolio startups. For fund there is no match between the location of its establishment and the land of its numerous investments - Sweden. Among the most successful fund investment fields, there are Medical, B2B. Among the various public portfolio startups of the fund, we may underline Themis Bioscience, AttgeNO, SAGA Diagnostics
Related Funds
| Fund Name | Location |
| Axell | Japan, Tokyo |
| Beacon Holding | California, Los Angeles, United States |
| Chart Industries | Ohio, Ohio City, United States |
| ForMED Ventures | Taipei, Taiwan |
| Heartland Dental | - |
| IMPACT Growth | - |
| Industrial Bank | China, Foochow, Fujian |
| Kyosemi | Japan, Kyoto, Kyoto Prefecture |
| Responder Ventures | Florida, United States, West Palm Beach |
| SDIC Unity Capital | Beijing, Beijing, China |
| Seamless | New York, New York, United States |
| Shuangliang Group | - |
| The Scoular Company | Nebraska, Omaha, United States |
| Trancos Ventures | Illinois, Lincolnshire, United States |
| Viewpoint Investment Partners | - |
| Walkabout Ventures | California, Los Angeles, United States |
| Yamcom Holdings BV | Afula, Israel, North District |
| Yunsheng Touzi | China, Jinshan District |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
SciRhom | $74M | 09 Jul 2024 | Martinsried, Bayern, Germany | ||
ARTHEx Biotech | $49M | 03 May 2023 | Valencia, Valencian Community, Spain | ||
Complement Therapeutics | $84M | 17 Apr 2023 | London, England, United Kingdom | ||
TargED Biopharmaceuticals | $46M | 19 Feb 2022 | Utrecht, Utrecht, The Netherlands | ||
Ribbon Biolabs | $21M | 31 Jan 2022 | Vienna, Austria | ||
Emergence Therapeutics | $102M | 07 Dec 2021 | Duisburg, Nordrhein-Westfalen, Germany | ||
Cardior Pharmaceuticals | $75M | 25 Aug 2021 | Hanover, Lower Saxony, Germany | ||
SAGA Diagnostics | $12M | 29 Jun 2021 | Sweden, Skåne County, Sweden | ||
Step Pharma | $41M | 24 Mar 2021 | Paris, Ile-de-France, France |
– Cardior Pharmaceuticals from Hanover develops non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases.
– The company closed a €64m ($76m) Series B financing round.
– The round was led by Inkef Capital, supported by fellow new investors Fund+, Sunstone, Hadean Ventures and Coparion with participation from existing investors including LSP, BioMedPartners, Bristol Myers Squibb and High-Tech Gründerfonds.
– The new investment will be used for the late-stage clinical development of its lead program and the expansion of its earlier-stage pipeline.
– Step Pharma, a biotech company developing novel drugs for oncology and autoimmune diseases, today announced the successful closing of a EUR35 million Series B financing.
– New investors Hadean Ventures and Sunstone Life Science Ventures co-led the round, joining existing investors Kurma Partners, Pontifax and Bpifrance, which reinvested through its Innovative Biotherapies and Rare Diseases fund and InnoBio 2 fund.
– As part of the financing, Jacob L Moresco from Sunstone Life Science Ventures and Walter Stockinger from Hadean Ventures will join the Step Pharma Board of Directors.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
SciRhom | $74M | 09 Jul 2024 | Martinsried, Bayern, Germany | ||
ARTHEx Biotech | $49M | 03 May 2023 | Valencia, Valencian Community, Spain | ||
Complement Therapeutics | $84M | 17 Apr 2023 | London, England, United Kingdom | ||
TargED Biopharmaceuticals | $46M | 19 Feb 2022 | Utrecht, Utrecht, The Netherlands | ||
Ribbon Biolabs | $21M | 31 Jan 2022 | Vienna, Austria | ||
Emergence Therapeutics | $102M | 07 Dec 2021 | Duisburg, Nordrhein-Westfalen, Germany | ||
Cardior Pharmaceuticals | $75M | 25 Aug 2021 | Hanover, Lower Saxony, Germany | ||
SAGA Diagnostics | $12M | 29 Jun 2021 | Sweden, Skåne County, Sweden | ||
Step Pharma | $41M | 24 Mar 2021 | Paris, Ile-de-France, France |
